Remdesivir in adults with severe COVID-19 :  a randomised, double-blind, placebo-controlled, multicentre trial / 
Yeming Wang [and forty one others] 
<br/><br/>In: The Lancet, 2020 Vol. 395 (10236)  page 1569-1578 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Nucleosides<br/>Prodrugs<br/>Coronavirus
<br/><br/><label>Subjects--Index Terms: </label>Remdesivir COVID-19